Drugs Made In America Acquisition II Corp. (DMIIU)
10.02
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
Price Chart
Key Stats
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | |
| Industry | |
| Next Earnings Release | Feb. 27, 2026 (est.) |
| Last Earnings Release | Nov. 18, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | |
| Industry | |
| Next Earnings Release | Feb. 27, 2026 (est.) |
| Last Earnings Release | Nov. 18, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |